Cynthia Flowers

Cynthia L.
Flowers is Chief Executive Officer at Omeza Holdings, Inc. since 2023.
Holds director roles at Cyber X Designs LLC (since 2021), Relevate Health Group LLC, Eternatear, Inc., Relevate Holdings LP, and is Owner of Eir Advisory LLC (since 2018).
Serves as Independent Non-Executive Director at Hikma Pharmaceuticals Plc and Hikma Ventures Ltd. since 2019.
Independent Director at Lisata Therapeutics, Inc. since 2018.
Member of the National Association of Corporate Directors (Virginia).
Formerly President & Chief Executive Officer at Eisai, Inc. from 2008 to 2010 and President & Chief Executive Officer-North America at Ipsen, Inc. from 2014 to 2017.
Director at Sarah Cannon Research Institute LLC from 2010 to 2013.
Independent Director at G1 Therapeutics, Inc. from 2018 to 2024.
Vice President & General Manager-US Oncology at Amgen, Inc. from 2005 to 2008.
Held director and senior vice president roles at various organizations including CenterLight Health System, Inc., Caladrius Biosciences, Inc., Nanoform Finland Oyj, Kadmon Holdings, Inc., and Optimer Pharmaceuticals LLC.
Education includes undergraduate degree from the University of Delaware and MBA from The Wharton School of the University of Pennsylvania.